Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04693767 · ClinicalTrials.gov registry record
Investigation of Clot in Ischemic Stroke and Hematoma Evacuation
A clinical trial of Ischemic Stroke and Intracranial Hematoma, sponsored by Penumbra.
- Completed
- Registry status
- 400
- Enrollment target
- 20
- Study locations
NCT04693767: Completed study of Ischemic Stroke and Intracranial Hematoma, sponsored by Penumbra.
NCT04693767 is a study of Ischemic Stroke and Intracranial Hematoma that has completed, run by Penumbra. The registered enrollment target is 400 participants, below the 1,458-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (73% lower). The trial reports 20 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04693767, a study of Ischemic Stroke and Intracranial Hematoma, has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 20
- Study locations
Study Summary
The aim of the study is to collect and analyze specimen from ischemic stroke patients undergoing thrombectomy procedures and from patients undergoing minimally invasive surgery for intracranial hematoma evacuation.
Primary Outcome
Numbers of clot specimen for histology analysis
Conditions Studied
Interventions
- DEVICE Mechanical thrombectomy
- OTHER Minimally invasive surgery
Study Locations (20)
New York
- Mount Sinai - New York
- Stony Brook University - Stony Brook
- Westchester Medical Center - Valhalla
Arizona
- Banner Desert Medical Center - Mesa
- Banner University Medical Center - Phoenix - Phoenix
Kentucky
- University of Kentucky - Lexington
- Norton Neuroscience Institute - Louisville
Delaware
- Christiana Care - Newark
District of Columbia
- George Washington University - Washington D.C.
Florida
- Baptist Medical Center - Jacksonville
Illinois
- Northwestern University - Chicago
Indiana
- Indiana University Health Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2021-02-16 |
| Est. Completion | 2022-08-03 |
What the finished NCT04693767 record still lists
NCT04693767 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,458-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which Mechanical thrombectomy is the first listed.
NCT04693767 names 20 study sites across 16 states, led by New York, Arizona, Kentucky.
Frequently Asked Questions
What is clinical trial NCT04693767 about?
NCT04693767 is a clinical study titled "Investigation of Clot in Ischemic Stroke and Hematoma Evacuation". The aim of the study is to collect and analyze specimen from ischemic stroke patients undergoing thrombectomy procedures and from patients undergoing minimally invasive surgery for intracranial hematoma evacuation.
What is the current status of trial NCT04693767?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2021-02-16. Estimated completion is 2022-08-03.
What conditions does trial NCT04693767 study?
This clinical trial studies the following conditions: Ischemic Stroke, Intracranial Hematoma.
What interventions are being tested in trial NCT04693767?
The interventions under investigation include: Mechanical thrombectomy (DEVICE), Minimally invasive surgery (OTHER).
Who is sponsoring clinical trial NCT04693767?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04693767 being conducted?
This trial has 20 study locations across Arizona, Delaware, District of Columbia, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04693767's enrollment target sits among peer trials
400 17th of 66 higher than 50 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Transitions of Care for Stroke Patients
RECRUITING
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI